Objective: Although the roles of testosterone and cortisol in various health problems have been extensively investigated, little is known about their associations with health outcomes in mothers and their very-low-birthweight (VLBW) infants when maternal testosterone and cortisol are examined together during the postpartum period. Method: The 101 mother-VLBW infant pairs were recruited from the neonatal intensive care unit of a tertiary medical center in the southeastern United States. Demographic information, pregnancy and labor complications of mothers, and health and growth outcomes of infants were obtained from medical records and interviews with mothers. Maternal salivary testosterone and cortisol levels were determined using enzyme immunoassay. Results: Linear regression showed that mothers who were older and had a larger body mass index experienced more pregnancy complications, whereas mothers who were single and had a cesarean section experienced more labor complications. Generalized linear models showed that mothers with high cortisol levels had more antepartum hemorrhage, whereas infants of mothers with high cortisol levels had fewer neurological insults and shorter hospitalizations than other infants. More mothers experienced premature prolonged rupture of membranes (PPROM) than chorioamnionitis, and maternal medical complications were negatively associated with infant health outcomes except PPROM, which was positively associated with infant outcomes. Conclusions: High maternal cortisol levels were associated with maternal health problems during pregnancy. Beneficial effects of PPROM and high maternal cortisol levels on infant health outcomes were important findings, and understanding the mechanisms of these relationships may be of practical value for clinicians and researchers.
Biological factors such as testosterone and cortisol levels are associated with women's physical and mental health outcomes as well as the health and growth outcomes of very-lowbirthweight (VLBW; birthweight < 1,500 g) infants (Carlsen, Jacobsen, & Romundstad, 2006; Cho, Carlo, Su, & McCormick, 2012; Giltay et al., 2012) . However, it is not known whether those hormonal biomarkers are concurrently associated with women's health during the peripartum period or whether maternal hormonal biomarkers are associated with the health outcomes of their VLBW infants. As testosterone levels of mothers and infants are less likely to be correlated than their cortisol levels (Sarkar, Bergman, O'Connor, & Glover, 2008) , maternal cortisol levels are likely more influential on infant health and developmental outcomes than maternal testosterone. However, because cortisol levels are positively correlated with testosterone levels in both women and infants (Cho et al., 2012; Sarkar et al., 2008) , studying the concurrent effects of these hormonal markers should provide a better understanding of their associations with maternal health outcomes and infant health and development.
Researchers have found testosterone to be negatively associated with women's health outcomes including ovarian cancer (Chen et al., 2011) , diabetes (Soriguer et al., 2012) , and rheumatoid arthritis (Cutolo, 2009) . During pregnancy, elevated testosterone levels are associated with preeclampsia and intrauterine growth retardation in humans (Carlsen et al., 2006) and other mammals (Manikkam et al., 2004) . In another study, elevated testosterone levels were positively associated with women's mental health such that women with high testosterone levels reported fewer depressive symptoms than women with normal or low testosterone levels (Giltay et al., 2012) .
Although infant testosterone levels are not dependent on maternal testosterone levels and research has revealed no association between testosterone levels in amniotic fluid and those in maternal blood (Troisi et al., 2003) , infants of mothers with elevated prenatal testosterone levels tend to have more health problems and physical growth delays than infants of mothers with normal testosterone levels (Furui, Imai, & Ohno, 2007) . Elevated maternal testosterone or androstenedione levels during pregnancy increase anti-Mü llerian hormone levels in fetuses (Hart et al., 2010) , resulting in increased risk for polycystic ovary syndrome in adolescent females (Abbott, Barnett, Bruns, & Dumesic, 2005) and testicular and prostate cancer in adolescent males (Holl et al., 2009) . Authors have also speculated that high intrauterine testosterone levels are a risk factor for neurodevelopmental disorders such as reading disability, autism, and attention-deficit-hyperactivity disorder (James, 2008) . Elevated maternal testosterone levels increase early catch-up growth in mammals (Manikkam et al., 2004) , which is a risk factor for adult onset of diseases such as hypertension and cancer.
As with testosterone, increased cortisol levels are associated with women's health outcomes including increased risk for hypertensive disorders (Hamer & Steptoe, 2012) , breast cancer (McGregor & Antoni, 2009) , and inflammatory disorders (Sapolsky, Romero, & Munck, 2000) . In women, stress leads to adrenocorticotrophic hormone (ACTH) secretion, which leads to activation of the adrenal gland, which increases cortisol and testosterone levels; whereas in men, stress increases cortisol levels and leads to a reduction in gonadotrophins and hence lower testosterone levels (Grant & Irwin, 2009 ). Maternal cortisol levels increase up to 2-4 times over the course of a pregnancy in response to endo-and exogenous stimuli, such as prenatal stress and corticosteroids (Reynolds, 2013) , and appear to affect both maternal health and infant health and growth. Authors have posited that elevated cortisol levels impair the neurological and immune systems because of the resultant increased permeability of the blood-brain barrier and immunosuppressive action of glucocorticoids (Sapolsky et al., 2000) . Thus, high maternal cortisol levels may be a biological risk factor for both mothers and their infants (Bolten et al., 2011) .
Elevated maternal prenatal cortisol levels are positively associated with preterm birth and delays in physical growth (Bolten et al., 2011) . Although maternal cortisol levels and stress are bidirectionally and positively correlated, maternal cortisol levels are better predictors of birth outcomes than maternal perceived stress. Prenatal cortisol levels play a critical role in the fetal immune system (Sapolsky et al., 2000) as this steroid hormone is involved in the production of passive immunity (Merlot, Couret, & Otten, 2008) and regulation of placental enzymes (Benediktsson, Calder, Edwards, & Seckl, 1997) . Thus, infants exposed to high levels of prenatal cortisol are more likely to be susceptible to illness during the postnatal period.
Testosterone and cortisol are thus important hormonal biomarkers of women's health, and maternal health is an important predictor of infant health and development (Duthie & Reynolds, 2013; Harvey et al., 2017) ; however, little information is available on their associations with maternal health during the peripartum period or with infant health and growth during the postnatal period. The rationale for measuring these steroid hormones concurrently is that both hormones are synthesized in adrenal tissue in women and infants and are released by stimulating each other (Sarkar et al., 2008) .
The purpose of this study was threefold: (1) to examine whether maternal salivary testosterone and cortisol levels are associated with maternal health outcomes as indicated by medical complications during pregnancy and at birth, (2) to examine whether maternal testosterone and cortisol levels are associated with infant health and growth outcomes, and (3) to examine whether maternal health problems are related with infant health and growth outcomes. We hypothesized that the levels of maternal testosterone and cortisol would be negatively associated with maternal health as well as infant health and growth, and maternal health problems would be positively associated with problematic infant health and growth.
Method
For this exploratory study, we used a descriptive and comparative research design.
Participants
We recruited a convenience sample of 101 mother-VLBW infant pairs, including three sets of twins, from the neonatal intensive care unit (NICU) of a tertiary medical center in the southeastern United States to which approximately 350 VLBW infants were admitted per year. We randomly included just one infant from each twin set to reduce duplication of maternal data. Maternal characteristics between mothers with single births and those with multiple births did not differ statistically. Because this investigation was an exploratory study for which we had little preliminary data, we took a liberal approach by assuming a power of 80% and a significance level of .05.
We recruited mothers who (a) had given birth within 2-7 days, (b) were older than 15 years to avoid including mothers who were too young to understand consent, and (c) spoke English. To reduce potential confounding effects, we excluded mothers if they (a) were dependent on narcotics or other drugs, (b) were HIV positive, or (c) had a documented serious medical or psychological problem such as cancer or postpartum psychosis. All participating mothers were considered at risk for preterm birth, thus 98% of mothers in this study had received at least one dose of 12 mg of betamethasone (BMZ) before birth. Among these mothers, 81% had received two doses of BMZ and 19% one dose 1 week before giving birth. We included infants if they were born at less than 34 weeks' gestational age (GA) and weighed less than 1,500 g at birth and excluded infants if they had congenital anomalies.
Measures
We obtained data through medical record review, interviews with mothers, and biochemical measurement. Maternal data included demographic information, pregnancy history, and birth record. Infant data included demographic information, birth record, and neonatal history.
Maternal health. We included six pregnancy complications as maternal health outcomes (diabetes, use of insulin, pregnancyinduced hypertension, chronic hypertension, antepartum hemorrhage, and chorioamnionitis) because of their potential to affect infant health. We created summed and unweighted binary variables (0 ¼ absence or no, 1 ¼ presence or yes) based on our previous studies (Cho et al., 2012) . The total possible score for pregnancy complications ranged from 0 to 6, with a higher score indicating more maternal health problems during pregnancy. We selected four labor complications as maternal health outcomes that could also affect infant health and growth: premature prolonged rupture of membranes (PPROM; spontaneous rupture of membranes before 37 weeks of gestation), use of antenatal steroids, use of antibiotics, and numbers of antibiotics used (0-6). The total possible score for labor complications ranged from 0 to 9, with a higher score indicating more maternal medical problems at birth.
Infant health. We selected infant health problems in seven categories to use as infant health outcomes, including GA, 1-and 5min Apgar scores, cardiopulmonary resuscitation at birth (CPR, possible score of 0-6, with higher scores indicating more problems), presence of medical complications (possible score of 0-16, with higher scores indicating more problems), days of hospitalization, technology dependence at discharge (possible score of 0-6, with higher scores indicating more problems), and degree of neurological insult according to the Neurobiologic Risk Score (NBRS; Brazy, Goldstein, Oehler, Gustafson, & Thompson, 1993) . The NBRS consists of seven possible neurological insults-mechanical ventilation, acidosis, seizures, intraventricular hemorrhage (IVH), periventricular leukomalacia (PVL), infection, and hypoglycemia-that are rated as 0, 1, 2, or 4 based on the severity and duration of the condition. The total NBRS is the sum of the scores on the 7 items and ranges from 0 to 28, with a higher score indicating a high prevalence of insults. The NBRS has correlations of À0.37 and À0.65 with the Bayley Mental and Psychomotor Indexes at 6 and 24 months' corrected age, respectively. Internal consistency of the NBRS was 0.66 in the present study. We created, summed, and unweighted binary variables (0 ¼ no, 1 ¼ yes) for CPR, medical complications, and technology dependence at discharge based on our previous studies (Cho et al., 2012) .
Infant growth. We obtained data on infant growth parameters (weight, length, and head circumference at birth, at Week 1, and at discharge) from the medical record. The infant was weighed on a battery-operated, electronic scale with a capacity of 20 kg and accuracy within 10 g. Length was measured on a collapsible board with increments to the nearest 0.25 cm. Head circumference was determined with a disposable tape that measured to the nearest 0.25 cm. NICU nurses measured all growth parameters between 4 a.m. and 6 a.m.
Testosterone. We measured maternal testosterone levels in saliva because saliva contains free steroids that are unbound to proteins and more biochemically relevant because of easy availability to tissues (Rosner, Auchus, Azziz, Sluss, & Raff, 2007) . We determined maternal salivary testosterone levels by enzyme immunoassay (EIA). Following the procedure recommended by the supplier (Salimetrics, LLC, State College, PA, https://www.salimetrics.com/assets/documents/1-2402n.pdf), we repeated the measurement for each sample and averaged the levels. The intra-and interassay coefficients of variation were 2.5% and 5.6%, respectively. We collected all maternal salivary samples before the infants in the NICU were at 40 weeks' postmenstrual age. Because testosterone levels are higher in the morning than in the evening (Granger et al., 2003) , we collected samples between 9 a.m. and noon to reduce variation due to the diurnal rhythm of testosterone and to avoid extremely low measures of testosterone levels.
Cortisol. Cortisol levels also vary diurnally and are higher in the morning than in the evening, so we used the same saliva samples for both testosterone and cortisol measurement. We determined salivary cortisol levels using EIA. We repeated the measurement for each sample and averaged them following the procedure recommended by the supplier (Salimetrics, https:// www.salimetrics.com/assets/documents/1-3002n.pdf). The intra-and interassay coefficients of variation for the present study were 3.3% and 3.7%, respectively.
Procedure
The university institutional review board approved the study. On a daily basis during the study period, a research nurse identified eligible mothers and their neonates through the NICU admission log. The research nurse discussed the study with the mothers and gave the informed-consent form to the mothers for their review. After maternal consent, a research nurse reviewed the medical records of the mothers and neonates and interviewed mothers to complete the data forms at the NICU before collecting maternal saliva samples.
We obtained saliva from mothers by having them use a straw to expectorate into a small tube 1 hr before or after any oral intake. We collected three saliva samples of saliva (0.1 ml each with at least a 15-min interval between samples) from each mother within a 2-hr period to minimize the effects of any pulsatile and diurnal secretion patterns of hormonal markers (Rosner et al., 2007) . We collected saliva samples without using collection devices such as a mouth swab or cotton roll because these devices can introduce assay artifacts. We placed all saliva samples on ice to transfer to the laboratory at the university, where they were stored in a À80 C freezer until assay.
Data Analysis
Generalized linear models (GLMs) were our primary analytic tools for determining whether maternal salivary testosterone and cortisol levels were associated with maternal health and infant health and growth outcomes and to adjust for maternal (age, race, body mass index [BMI], education, and marital status) and of infant (gender) characteristics and the number of days after birth on which saliva collection occurred. We considered the last item to be a covariate because saliva sample collection times varied among mothers. Depending on the response variables, we used different types of GLMs for analysis. We used a log-linear regression for count responses (e.g., testosterone and cortisol levels) and logistic regression for binary outcomes (e.g., presence or absence of maternal health problems). We used t tests and w 2 tests to compare maternal and infant demographic characteristics between infant genders. We used linear regression to examine bivariate associations with maternal salivary testosterone and cortisol levels as well as with pregnancy and labor complications. We also used linear regression to examine associations between maternal health and infant health and growth outcomes.
Results

Characteristics of Mothers and Infants and Maternal Steroid Hormone Levels
Of the 101 participating mothers, 43% had more than a high school education, 38% were married, 49% were Caucasian, 57% had a cesarean section, and 34% had private insurance. Mean maternal age was 25 years. Mean gravida and parity were 2.3 and 1.4, respectively, and mean prepregnancy BMI was 33.3 kg/m 2 . Approximately 90% of mothers had medical complications during pregnancy, most often one (58%) or two (21%) complications, including gestational hypertension (56%), chorioamnionitis (33%), chronic hypertension (23%), diabetes mellitus (10%), antepartum hemorrhage (7%), and use of insulin (7%). Also, 99% of mothers had medical complications at birth, most often three (29%), four (30%), or five (23%) complications, including use of steroids (98%), use of antibiotics (90%), most often one (51%) or two (29%) antibiotics, and PPROM (53%). The demographic characteristics of mothers did not differ significantly between mothers of boys and mothers of girls except that mothers of girls had more medical complications at birth than mothers of boys (t ¼ 2.234, df ¼ 99, p ¼ .03).
Of the 101 infants in the sample, 45 were boys and 56 were girls. Mean GA and birthweight of infants were 29 weeks and 1,094 g. Mean 1-and 5-min Apgar scores were 4.3 and 6.9, respectively. Mean resuscitation at birth (0À6), medical complications at birth (0-16), and neurological insults (0-28) were 2.0, 2.7, and 1.9, respectively. Infants stayed at the hospital a mean of 62 days, and 16 (17%) infants were dependent on medical technology at discharge. Demographic characteristics of infants did not differ between boys and girls except that boys had larger head circumferences at birth (t ¼ 2.185, df ¼ 99, p ¼ .03) and were heavier at the first week (t ¼ 2.234, df ¼ 99, p ¼ .03) than girls.
The overall mean maternal testosterone level was 52.9 pg/ ml and did not differ between mothers of male infants and mothers of female infants (49.7 vs. 55.5 pg/ml, t ¼ À1.348, df ¼ 99, p ¼ .19). Overall mean maternal cortisol level was 0.2 mg/dl and did not differ between mothers of male infants and mothers of female infants (0.17 vs. 0.20 mg/dl, t ¼ À1.350, df ¼ 99, p ¼ .18).
Associations of Maternal Characteristics With Maternal Steroid Hormone Levels and Maternal Health
Simple linear regressions for bivariate associations of maternal testosterone and cortisol levels with maternal demographic characteristics showed that none of the demographic characteristics of mothers differed by either maternal testosterone or cortisol levels except that White mothers had higher cortisol levels than non-White mothers (r 2 ¼ .041
On the other hand, as shown in Table  1 , bivariate associations of maternal medical complications during pregnancy and at birth with maternal demographic characteristics showed that mothers who were older and had a larger BMI experienced more complications during pregnancy, whereas mothers who were single and delivered via a cesarean section had more complications during labor than other mothers. Significantly, more mothers had a cesarean section than a vaginal delivery (57.4% vs. 42.6%; w 2 ¼ 25.496, df ¼ 8, p ¼ .001). Table 2 presents results from log-linear regression (for count responses, testosterone, and cortisol levels) and logistic regression (for binary outcomes, presence or absence of health problems during pregnancy and at birth) analyses for assessing the associations of maternal testosterone and cortisol levels with maternal health outcomes. Maternal testosterone levels were not significantly associated with maternal medical complications during pregnancy or at birth after controlling for the covariates (characteristics of mothers and infants and days after birth of saliva collection). Mothers with high cortisol levels experienced significantly more antepartum hemorrhage than mothers with low cortisol levels, but this relationship ceased to be significant after we controlled for the covariates.
Associations Between Maternal Steroid Hormone Levels and Maternal Health
Associations Between Maternal Steroid Hormone Levels and Infant Health and Growth
The results of GLMs for examining associations between maternal steroid hormone levels and infant health and growth outcomes, presented in Table 3 , revealed a trend, but not a significant association, for infants of mothers with high testosterone levels having smaller head circumferences at birth than infants of mothers with low testosterone levels after we controlled for the covariates. Infants of mothers with high cortisol levels had fewer neurological insults and shorter hospitalizations than the infants of mothers with low cortisol levels after controlling for the covariates. We also found a trend, but not a significant association, for infants of mothers with high cortisol levels having smaller head circumferences at discharge from the hospital than infants of mothers with low cortisol levels after we controlled for the covariates.
Associations Between Maternal Health and Infant Health and Growth
The results of linear regression for examining associations between maternal health and infant health outcomes, provided in Table 4 , showed that maternal medical complications were negatively associated with infant health (GA and 1-min Apgar score) and growth (length at discharge) after controlling for covariates. Specifically, infants of mothers with chorioamnionitis and those with mothers who received more antibiotics had lower GA, infants of mothers with antepartum hemorrhage had lower 1-min Apgar scores, and infants of mothers with chronic hypertension had shorter lengths at discharge. PPROM in mothers was positively associated with infant health (GA, receiving CPR at birth, days of hospitalization, degree of neurological insult, numbers of medical complications) and growth (weight, length, and head circumference at birth and at the first week as well as length at discharge) after controlling for covariates. Specifically, infants of mothers with PPROM had higher GA, less need for CPR, fewer medical complications at birth, and shorter hospitalizations. They were also heavier and taller and had a larger head circumference at birth and at the first week and were taller at discharge. Infants of mothers who received more antibiotics had lower GA. As we conducted many statistical analyses, multiplicity could be a concern, raising the possibility of more Type I errors. Because of the exploratory nature of this study, however, we did not make additional adjustments to avoid Type I errors.
Discussion
Associations of steroid hormone levels, specifically, testosterone and cortisol, with women's health have been intensively investigated. However, their associations with maternal outcomes during pregnancy and birth and infant outcomes are less clear. In the present study, we explored these associations after controlling for maternal (age, race, BMI, education, and marital status) and infant characteristics (gender) and days after birth of saliva collection. We had expected that elevated maternal steroid hormone levels would be negatively associated with maternal physical health, as indicated by medical complications during pregnancy and at labor, as well as infant health and growth. Accordingly, before controlling for the covariates, we found that mothers with high cortisol levels experienced more antepartum hemorrhage. On the other hand, after controlling for the covariates, we found that infants of mothers with high cortisol levels showed fewer neurological insults and shorter hospitalizations than infants of mothers with normal or low cortisol levels. Also, infants of mothers with PPROM had more favorable health and growth outcomes than infants of mothers without PPROM. The latter finding was unexpected, and we will discuss it in detail below.
Associations of Maternal Characteristics With Maternal Steroid Hormone Levels and Health Outcomes During Peripartum Period
First, we explored the associations between maternal characteristics with maternal steroid hormone levels. We found that maternal testosterone levels were not associated with maternal demographic characteristics and that maternal cortisol levels were higher in White mothers than non-White mothers. In a longitudinal study, non-White women showed flatter diurnal cortisol levels than White women across days and years, which the authors attributed to the fact that non-White women experienced more psychosocial stress (DeSantis, Adam, Hawkley, Kudielka, & Cacioppo, 2015) . In another study, plasma cortisol levels were higher in nondepressed, nonobese non-White women than in depressed and obese non-White women (Luiza, Gallaher, & Powers, 2015) . Based on these findings, low cortisol levels among non-White mothers should not be considered an indicator of positive maternal health outcomes. Second, we examined whether maternal medical problems during pregnancy and at labor were associated with maternal demographic characteristics. Both pregnancy and labor complications were more common in mothers who had a cesarean section. This finding was not surprising because mothers with more medical complications are more likely to have cesarean deliveries to minimize risks during childbirth. We also found that older maternal age and larger BMI were risk factors for pregnancy complications, whereas single marital status and cesarean section were associated with labor complications. Older age, elevated BMI, and single marital status are known risk factors for maternal health problems in pregnancy (Danieli-Gruber, Maayan-Metzger, Schushan-Eisen, Strauss, & Leibovitch, 2017) .
Associations Between Maternal Steroid Hormone Levels and Maternal and Infant Health
Maternal testosterone levels were not associated with maternal health outcomes, measured as medical complications during pregnancy and birth, or with infant health and growth except that infants whose mothers had higher levels of testosterone had a smaller head circumference at birth. However, high cortisol levels were associated with more antepartum hemorrhage in our analyses before we controlled for the covariates; after controlling for the covariates, we still found a trend toward mothers with higher cortisol levels experiencing more antepartum hemorrhage than mothers with low cortisol levels. Prior research has found a positive association between antepartum hemorrhage and plasma ACTH concentrations . Increased concentrations of ACTH lead to increased cortisol levels through activation of the adrenal gland. Further, cord plasma ACTH levels were increased in neonates of mothers with exposure to prenatal life stressors. Thus, it might be that the mothers who demonstrated higher cortisol levels and more antepartum hemorrhage had more exposure to stressors in the prenatal period than mothers without antepartum hemorrhage.
In a previous study, we found that delayed infant growth was associated with elevated neonatal testosterone levels but not maternal testosterone levels (Cho et al., 2012) . We had expected that elevated maternal cortisol levels would be negatively associated with infant health outcomes because other researchers have found that high maternal cortisol levels at late pregnancy were negatively associated with infant outcomes (de Weerth, van Hees, & Buitelaar, 2003) . In de Weerth et al.'s study, infants of mothers with high cortisol levels at late gestation were born earlier and showed more difficult temperaments than infants of mothers with low cortisol levels. However, in the present study, we found that infants of mothers with elevated cortisol levels had fewer neurological insults, shorter hospitalization, and larger head circumference at discharge, after we controlled for the covariates, than did infants of mothers with low cortisol levels. This association between higher maternal cortisol levels and positive infant health outcomes was unexpected. It is possible that the cortisol levels of the mothers and infants are not be positively correlated, but we did not measure infant cortisol levels in the present study. Another possible explanation for this unexpected finding is that maternal cortisol levels during the prenatal period may be more influential on infant outcomes than the levels in the postnatal period because maternal cortisol levels decline significantly after childbirth, and, in fact, prior studies have reported a lack of association between postnatal maternal cortisol levels and infant outcomes (Zijlmans, Riksen-Walraven, & de Weerth, 2015) . On the other hand, high maternal cortisol levels at early gestation were associated with slower rate of infant growth at 12 months in another study (Davis & Sandman, 2010 ). Finally, it is possible that basal cortisol levels are lower in preterm than term neonates and that the low cortisol levels are associated with suppressed response to exposure to stressors at the NICU (Weiss & Niemann, 2015) . We previously found that VLBW infants with lower postnatal cortisol levels showed fewer positive interactive behaviors toward their mothers at 3-6 months corrected age for prematurity (Cho, Su, Phillips, & Holditch-Davis, 2015) .
In our previous study, we found that neonatal heath and growth were more closely associated with neonatal testosterone levels than neonatal cortisol levels (Cho et al., 2012) . In the present study, however, our findings suggest that maternal health and infant health and growth are more closely associated with maternal cortisol levels than maternal testosterone levels. Our findings may be explained by the fact that testosterone levels are very low in women, and thus, it might not be present in large enough quantities to affect maternal and infant health outcomes. Also, there was a low correlation between testosterone and cortisol levels in mothers in the present study (r ¼ .231 and r 2 ¼ .05); thus, the chance of successfully predicting maternal and infant outcomes using maternal testosterone levels would differ from the chance of using cortisol levels.
Associations Between Maternal Health and Infant Health and Growth
As we had expected, maternal medical complications during pregnancy (antepartum hemorrhage, chorioamnionitis, and chronic hypertension) and at birth (numbers of antibiotics used), except for PPROM, were negatively associated with infant health and growth. For example, among many maternal risk factors for problematic infant outcomes, when mothers suffered from antepartum hemorrhage, their VLBW infants required intermittent positive-pressure ventilation or highfrequency oscillation ventilation and had higher plasma ACTH concentrations (Ng et al., 2002) . Thus, VLBW infants of mothers with more health problems are likely to be at increased risk for problematic health and growth outcomes.
Interestingly, however, the infants of mothers with PPROM had fewer negative health and growth outcomes than infants of mothers without PPROM. This association was unexpected since prior research has led us to expect an association between maternal medical complications and negative infant health outcomes (Armstrong-Wells et al., 2015) . One possible explanation for this finding is that the PPROM may not be always a risk factor for VLBW preterm infants since research has shown chorioamnionitis and funisitis, which some mothers with PPROM develop, to be beneficial to preterm infants because they decrease risk for late-onset sepsis and respiratory distress syndrome (Lee et al., 2011; Strunk et al., 2012) .
A recent study showed that infants of mothers with early PPROM (<25 weeks' gestation at rupture) were born more than 3 weeks earlier and had higher rates of severe neonatal (sepsis, severe IVH, PVL, severe necrotizing enterocolitis, bronchopulmonary dysplasia, and death) and childhood (i.e., 2 years of age; moderate or severe cerebral palsy and/or low cognitive and motor development scores more than 2 SD below the means) morbidity than infants of mothers with late PPROM (!25 weeks' gestation at rupture; Manuck & Varner, 2014) . As the majority of mothers in this study experienced PPROM at 28 weeks' gestation (range, 24-33 weeks) and had a 5-day rupture-to-birth interval (range, 0-41 days), problems related with either early PPROM or a long duration of PPROM might not have affected the infant outcomes. Because all the mothers in this study were at risk for preterm birth, it is possible that infants of the mothers with PPROM were more likely to have been exposed to preventive treatments such as BMZ and antibiotics prior to birth than other premature infants. Also, the standard care for mothers with PPROM, such as bed rest, might provide a safer prenatal condition for fetal development. In any case, we recommend that future research examines the mechanisms of the associations we found between PPROM and positive infant health outcomes.
Limitations
This study had a few limitations. First and most importantly, dose and time effects of prenatal corticosteroids might have affected maternal testosterone and cortisol levels; however, we did not control for these factors because 98% of mothers received such treatment before birth and enrollment. Second, as we mentioned in the Results section, multiplicity could be a concern because of the possibility of more Type I errors. Given the large number of tests, the small number of significant results could include chance findings.
Conclusion
Prior research has shown a positive relationship between testosterone and cortisol levels in women. However, in the present study, we found that only maternal cortisol levels, and not maternal testosterone levels, were associated with maternal health and infant health and growth outcomes during the peripartum period. The beneficial effects of PPROM and high maternal cortisol levels on infant health outcomes were important findings of the present study and may be of practical value for clinicians and researchers. Future studies examining mechanisms of the positive associations of PPROM on infant outcomes are needed.
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